Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway inEscherichia coli enhances lycopene production

Biotechnology and Bioengineering
2001.0

Abstract

Isopentenyl diphosphate (IPP) is the common, five-carbon building block in the biosynthesis of all carotenoids. IPP in Escherichia coli is synthesized through the nonmevalonate pathway, which has not been completely elucidated. The first reaction of IPP biosynthesis in E. coli is the formation of 1-deoxy-D-xylulose-5-phosphate (DXP), catalyzed by DXP synthase and encoded by dxs. The second reaction in the pathway is the reduction of DXP to 2-C-methyl-D-erythritol-4-phos- phate, catalyzed by DXP reductoisomerase and encoded by dxr. To determine if one or more of the reactions in the nonmevalonate pathway controlled flux to IPP, dxs and dxr were placed on several expression vectors under the control of three different promoters and transformed into three E. coli strains (DH5alpha, XL1-Blue, and JM101) that had been engineered to produce lycopene. Lycopene production was improved significantly in strains transformed with the dxs expression vectors. When the dxs gene was expressed from the arabinose-inducible araBAD promoter (P(BAD)) on a medium-copy plasmid, lycopene production was twofold higher than when dxs was expressed from the IPTG-inducible trc and lac promoters (P(trc) and P(lac), respectively) on medium-copy and high-copy plasmids. Given the low final densities of cells expressing dxs from IPTG-inducible promoters, the low lycopene production was probably due to the metabolic burden of plasmid maintenance and an excessive drain of central metabolic intermediates. At arabinose concentrations between 0 and 1.33 mM, cells expressing both dxs and dxr from P(BAD) on a medium-copy plasmid produced 1.4-2.0 times more lycopene than cells expressing dxs only. However, at higher arabinose concentrations lycopene production in cells expressing both dxs and dxr was lower than in cells expressing dxs only. A comparison of the three E. coli strains transformed with the arabinose-inducible dxs on a medium-copy plasmid revealed that lycopene production was highest in XL1-Blue.

Knowledge Graph

Similar Paper

Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway inEscherichia coli enhances lycopene production
Biotechnology and Bioengineering 2001.0
Exploiting exogenous MEP pathway genes to improve the downstream isoprenoid pathway effects and enhance isoprenoid production in Escherichia coli
Process Biochemistry 2015.0
Antisense and chemical suppression of the nonmevalonate pathway affects ent -kaurene biosynthesis in Arabidopsis
Planta 2002.0
Growth-phase Dependent Expression of the Mevalonate Pathway in a Terpenoid Antibiotic-producing<i>Streptomyces</i>Strain
Bioscience, Biotechnology, and Biochemistry 2002.0
Utilization of biodiesel by-product as substrate for high-production of β-farnesene via relatively balanced mevalonate pathway in Escherichia coli
Bioresource Technology 2017.0
Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective
European Journal of Medicinal Chemistry 2021.0
Construction of carotenoid biosynthetic pathways using squalene synthase
FEBS Letters 2014.0
Temperature‐sensitive <i>Arabidopsis</i> mutant defective in 1‐deoxy‐<scp>d</scp>‐xylulose 5‐phosphate synthase within the plastid non‐mevalonate pathway of isoprenoid biosynthesis
Physiologia Plantarum 2000.0
Cloning of a Gene Cluster Encoding Enzymes Responsible for the Mevalonate Pathway from a Terpenoid-antibiotic-producing Streptomyces Strain
Bioscience, Biotechnology, and Biochemistry 2001.0
A synthetic biology approach to transform <i>Yarrowia lipolytica</i> into a competitive biotechnological producer of β‐carotene
Biotechnology and Bioengineering 2018.0